BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12206806)

  • 1. Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice.
    Boer JM; de Meijer EJ; Mank EM; van Ommen GB; den Dunnen JT
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S118-24. PubMed ID: 12206806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression rate of myogenic regulatory factors and muscle growth factor after botulinum toxin A injection in the right masseter muscle of dystrophin deficient (mdx) mice.
    Botzenhart UU; Gerlach R; Gredes T; Rentzsch I; Gedrange T; Kunert-Keil C
    Adv Clin Exp Med; 2019 Jan; 28(1):11-18. PubMed ID: 30085421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model.
    Reano S; Angelino E; Ferrara M; Malacarne V; Sustova H; Sabry O; Agosti E; Clerici S; Ruozi G; Zentilin L; Prodam F; Geuna S; Giacca M; Graziani A; Filigheddu N
    Stem Cells; 2017 Jul; 35(7):1733-1746. PubMed ID: 28436144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A web-accessible complete transcriptome of normal human and DMD muscle.
    Bakay M; Zhao P; Chen J; Hoffman EP
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S125-41. PubMed ID: 12206807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse.
    Kuznetsov AV; Winkler K; Wiedemann FR; von Bossanyi P; Dietzmann K; Kunz WS
    Mol Cell Biochem; 1998 Jun; 183(1-2):87-96. PubMed ID: 9655182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
    Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
    Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does dystrophin deficiency lead to muscle degeneration?--evidence from the mdx mouse.
    McArdle A; Edwards RH; Jackson MJ
    Neuromuscul Disord; 1995 Nov; 5(6):445-56. PubMed ID: 8580726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles.
    McIntosh LM; Garrett KL; Megeney L; Rudnicki MA; Anderson JE
    Anat Rec; 1998 Oct; 252(2):311-24. PubMed ID: 9776086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent upregulation of the β-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle.
    Randazzo D; Khalique U; Belanto JJ; Kenea A; Talsness DM; Olthoff JT; Tran MD; Zaal KJ; Pak K; Pinal-Fernandez I; Mammen AL; Sackett D; Ervasti JM; Ralston E
    Hum Mol Genet; 2019 Apr; 28(7):1117-1135. PubMed ID: 30535187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
    Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
    Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
    Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
    Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling.
    Turk R; Sterrenburg E; de Meijer EJ; van Ommen GJ; den Dunnen JT; 't Hoen PA
    BMC Genomics; 2005 Jul; 6():98. PubMed ID: 16011810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological control of cellular calcium handling in dystrophic skeletal muscle.
    Ruegg UT; Nicolas-Métral V; Challet C; Bernard-Hélary K; Dorchies OM; Wagner S; Buetler TM
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S155-61. PubMed ID: 12206810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of dystrophin expression in skeletal muscle is associated with senescence of macrophages and endothelial cells.
    Young LV; Morrison W; Campbell C; Moore EC; Arsenault MG; Dial AG; Ng S; Bellissimo CA; Perry CGR; Ljubicic V; Johnston AP
    Am J Physiol Cell Physiol; 2021 Jul; 321(1):C94-C103. PubMed ID: 33979211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy.
    Yuasa K; Hagiwara Y; Ando M; Nakamura A; Takeda S; Hijikata T
    Cell Struct Funct; 2008; 33(2):163-9. PubMed ID: 18827405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice.
    Porter JD; Khanna S; Kaminski HJ; Rao JS; Merriam AP; Richmonds CR; Leahy P; Li J; Guo W; Andrade FH
    Hum Mol Genet; 2002 Feb; 11(3):263-72. PubMed ID: 11823445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized expression of specific P2X receptors in dystrophin-deficient DMD and mdx muscle.
    Jiang T; Yeung D; Lien CF; Górecki DC
    Neuromuscul Disord; 2005 Mar; 15(3):225-36. PubMed ID: 15725584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
    Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
    Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.